Compare Abbott Laboratories (ABT) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Teucrium Wheat Fund — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Teucrium Wheat Fund trades at $22.85. The key difference: Abbott Laboratories pays a 2.63% dividend while Teucrium Wheat Fund pays none, and Teucrium Wheat Fund is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | WEAT | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $136.62 | $25.49 |
52-Week Low | $82.57 | $19.88 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
WEAT (Teucrium Wheat Fund) trades at $22.93, up 2.32% today, while technical indicators signal a bearish trend with moving averages showing sell pressure. The fund faces headwinds from reduced USDA wheat production forecasts and inflation concerns. Key support sits at $22 with resistance at $23, creating a tight trading range amid neutral oscillator readings.
Outlook remains cautious given agricultural commodity volatility and macroeconomic pressures. Investment opportunity exists for hedging against inflation, but risks include weather-dependent production and Federal Reserve policy impacts on commodity prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
